lucinactant
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Lucinactant is a novel synthetic surfactant, approved by the FDA on March 6 th 2012, for use in treatment of RDS. It’s…
New molecular entity: FDA approved lucinactant (Surfaxin, Discovery Laboratories) for the prevention of respiratory distress…
Recent FDA action (through June 2009) related to lucinactant, fenretinide, fampridine-SR, HPN-100, vitespen, and prodarsan
Thank you for allowing me to respond to Dr Russell Clayton’s letter which I enjoyed reading. Dr Clayton’s concerns center on one…
Development and validation of a gradient, reversed-phase HPLC-CAD method simultaneously determining all protein, lipid and lipid…
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the…
Gateways to Clinical Trials is a guide to the most recent clinical trials in current literature and congresses. The data in the…